REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 131 filers reported holding REVOLUTION MEDICINES INC in Q2 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $413,000 | +81.9% | 14,899 | +75.4% | 0.00% | – |
| Q2 2023 | $227,000 | +106.4% | 8,495 | +66.5% | 0.00% | – |
| Q1 2023 | $110,000 | -53.0% | 5,103 | -48.0% | 0.00% | – |
| Q4 2022 | $234,000 | +963.6% | 9,818 | +786.1% | 0.00% | – |
| Q3 2022 | $22,000 | +100.0% | 1,108 | +99.6% | 0.00% | – |
| Q2 2022 | $11,000 | -88.8% | 555 | -85.6% | 0.00% | – |
| Q1 2022 | $98,000 | +16.7% | 3,850 | +16.0% | 0.00% | – |
| Q4 2021 | $84,000 | +75.0% | 3,320 | +89.2% | 0.00% | – |
| Q3 2021 | $48,000 | -65.0% | 1,755 | -41.4% | 0.00% | – |
| Q1 2021 | $137,000 | +585.0% | 2,994 | +503.6% | 0.00% | – |
| Q4 2020 | $20,000 | +1900.0% | 496 | +1553.3% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 30 | +20.0% | 0.00% | – |
| Q2 2020 | $1,000 | -93.3% | 25 | -96.5% | 0.00% | – |
| Q1 2020 | $15,000 | – | 708 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,104,130 | $99,479,000 | 40.69% |
| Ponoi II Management, LLC | 685,011 | $13,351,000 | 36.28% |
| Nextech Invest Ltd. | 3,939,529 | $76,781,000 | 25.90% |
| Ponoi Management, LLC | 685,011 | $13,351,000 | 21.08% |
| Column Group LLC | 4,395,050 | $85,660,000 | 18.23% |
| TRV GP IV, LLC | 1,419,900 | $27,674,000 | 18.20% |
| Boxer Capital, LLC | 3,484,264 | $67,908,000 | 4.30% |
| Casdin Capital, LLC | 2,370,000 | $46,191,000 | 3.91% |
| Cormorant Asset Management, LP | 1,995,066 | $38,884,000 | 2.94% |
| EcoR1 Capital, LLC | 4,278,069 | $83,380,000 | 2.88% |